Skip to content

Clinical trials

Phase 1 Lymphoma, Large B-Cell, Diffuse trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large B-Cell, Diffuse Phase: Phase 1 Country / region: Taiwan Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20131
20212
20221
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting3
Terminated3
Completed1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
ADC Therapeutics S.A.1
AbbVie1
AstraZeneca1
Eden BioCell Ltd.1
Genmab1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large B-Cell, Diffuse7
Lymphoma, Non-Hodgkin3
Lymphoma, B-Cell2
Lymphoma, Follicular2
Neoplasms2
Recurrence2
Burkitt Lymphoma1
Leukemia1
Leukemia, Lymphocytic, Chronic, B-Cell1
Lymphoma1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.